Evaristo M.
- Country
- Italy
- Department
- Oncologia
Research Overview
- A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus Bevacizumab and FOLFIRI in Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)
- Evaluation of Overall Survival in Metastatic Pancreatic Ductal Adenocarcinoma with SBP-101, Nab-Paclitaxel, and Gemcitabine Therapy
- Z0011001-A PHASE 1/2, OPEN-LABEL, MULTI-CENTER STUDY OF ZN-c3 ADMINISTERED IN COMBINATION WITH ENCORAFENIB AND CETUXIMAB IN ADULTS WITH METASTATIC COLORECTAL CANCER
Data & Insights
Has run more than one trial at 14 of 92 partner sites.
Specializations
Colorectal Cancer Research
This investigator specializes in treating metastatic colorectal cancer, with particular focus on patients with specific genetic profiles including RAS/BRAF mutations. Their research encompasses various therapeutic approaches using targeted combinations with cetuximab and novel immunotherapy agents.
- BRAF V600E-mutant metastatic disease
- MSI-H/dMMR colorectal cancer
- Biomarker-driven treatment strategies
Other Solid Tumors
The investigator conducts research across multiple advanced solid tumor types, including melanoma, cholangiocarcinoma, and pancreatic ductal adenocarcinoma. Their work involves novel therapeutic combinations and targeted approaches.
- Gastroesophageal adenocarcinoma
- Non-small cell lung cancer
- Urothelial carcinoma
Treatment Innovations
The investigator explores innovative therapeutic strategies including immunotherapy combinations and targeted molecular therapies. Their research includes studies of maintenance therapy approaches and novel drug combinations for various cancer types.
- Biomarker-driven treatment selection
- Sequential versus concurrent therapy
- First-in-human studies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.